These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 7298289

  • 1. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
    Pak CY.
    Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
    [Abstract] [Full Text] [Related]

  • 2. Sodium cellulose phosphate-induced increment in urinary calcium/magnesium ratio.
    Revusova V, Gratzlova J, Zvara V, Kridl J, Landsmanova L.
    Eur Urol; 1975 Nov; 1(6):294-6. PubMed ID: 1233199
    [Abstract] [Full Text] [Related]

  • 3. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
    Hering F, Lutzeyer W.
    Eur Urol; 1979 Nov; 5(1):29-31. PubMed ID: 428408
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis and management of hypercalciuric nephrolithiasis.
    Breslau NA.
    Miner Electrolyte Metab; 1994 Nov; 20(6):328-39. PubMed ID: 7783695
    [Abstract] [Full Text] [Related]

  • 5. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 6. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P.
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY, Delea CS, Bartter FC.
    N Engl J Med; 1974 Jan 24; 290(4):175-80. PubMed ID: 4808916
    [No Abstract] [Full Text] [Related]

  • 10. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER, Cohanim M.
    Clin Invest Med; 1986 Jan 24; 9(1):44-50. PubMed ID: 3955921
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B.
    Schweiz Med Wochenschr; 1995 Dec 26; 125(51-52):2460-70. PubMed ID: 8571096
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and chemical factors in kidney calculus formation in childhood. An analysis of 40 patients].
    Böhles H, Brandl U, Schott G, Stehr K.
    Monatsschr Kinderheilkd; 1984 Mar 26; 132(3):158-62. PubMed ID: 6727888
    [Abstract] [Full Text] [Related]

  • 13. [On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)].
    Ziegler R, Uhl K, Minne H, Russmann D, Döring B.
    Urologe A; 1980 Jul 26; 19(4):226-30. PubMed ID: 7414768
    [Abstract] [Full Text] [Related]

  • 14. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS, Hruska KA, Chandhoke PS.
    J Urol; 2003 Jun 26; 169(6):2030-3. PubMed ID: 12771711
    [Abstract] [Full Text] [Related]

  • 15. [Renal tubular function in children with hypercalciuria].
    Kovacević L, Kovacević S, Smoljanić Z, Kostić M, Peco-Antić A, Gajić M, Kovacević M, Jovanović O.
    Srp Arh Celok Lek; 1998 Jun 26; 126(7-8):223-7. PubMed ID: 9863386
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of hypercalciuria with thiazides, sodium or potassium cellulose phosphate, separately or in combination.
    Lutzeyer W, Hering F, Hautmann R.
    Trans Am Assoc Genitourin Surg; 1979 Jun 26; 71():67-9. PubMed ID: 545817
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic treatment of calcium calculi.
    Preminger GM.
    Urol Clin North Am; 1987 May 26; 14(2):325-33. PubMed ID: 3576853
    [Abstract] [Full Text] [Related]

  • 18. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M, Yendt ER.
    Invest Urol; 1980 Sep 26; 18(2):170-3. PubMed ID: 7410033
    [Abstract] [Full Text] [Related]

  • 19. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T.
    Hinyokika Kiyo; 1993 May 26; 39(5):425-31. PubMed ID: 8322624
    [Abstract] [Full Text] [Related]

  • 20. [Functional evaluation in patients with kidney calculi].
    Stojimirović B.
    Srp Arh Celok Lek; 1998 May 26; 126(9-10):394-8. PubMed ID: 9863414
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.